Literature DB >> 17980278

Acute abdominal aortic dissection: insight from the International Registry of Acute Aortic Dissection (IRAD).

Santi Trimarchi1, Thomas Tsai, Kim A Eagle, Eric M Isselbacher, Jim Froehlich, Jeanna V Cooper, Vincenzo Rampoldi, Gilbert R Upchurch.   

Abstract

BACKGROUND: Isolated acute dissection of the abdominal aorta is an unusual event that may present with several different clinical scenarios. Because its incidence is low, the natural history is unknown. We report data from the International Registry of Acute Aortic Dissection (IRAD), the largest group of patients treated for acute aortic dissections. The aim of this study was to identify clinical characteristics, therapeutic approaches, risk factors for mortality, in-hospital outcome, and long-term results of this cohort, thus clarifying its natural history.
METHODS: A comprehensive analysis of 290 clinical variables on 18 patients affected by isolated acute abdominal aortic dissection (IAAAD) was performed. Among 1417 patients enrolled in the IRAD from 1996 to 2003, 532 (37.5%) had an acute type B dissection, of which 18 (1.3%) had an IAAAD. Theor mean age was 67.7 +/- 13.3 years, with a male predominance (n = 12, 67%). Aortic aneurysms pre-existed in 5 patients (28%). IAAAD was iatrogenic in 2 cases (11%).
RESULTS: Compared with patients with type B aortic dissections, abdominal pain, mesenteric ischemia or infarction, limb ischemia, and hypotension as initial clinical signs were significantly more frequent in patients with IAAAD, whereas chest pain was more typical in patients with type B dissections. No neurologic symptoms, such as ischemic spinal cord damage or ischemic peripheral neuropathy, occurred in the IAAAD cohort. The 18 IAAAD patients were medically, surgically, or percutaneously managed in 12 (66.6%), five (27.8%), and one (5.6%) cases, respectively. The overall in-hospital mortality rate was 5.6% (n = 1). The patient who died was medically managed. No deaths were reported among patients who underwent surgery or had an endovascular procedure, irrespective of their preoperative status. A mean follow-up of 5 years (range, 1 month to 9 years) was completed for 71% (12 of 17) of the patients. Four patients (33.3%) died during the 9-year follow-up period. Overall survival was 93.3% +/- 12.6% at 1 year and 73.3% +/- 27.2% at 5 years. All patients who died during the follow-up period had in-hospital medical management (P = .04).
CONCLUSIONS: IAAAD is a condition that may present differently compared with classic type B aortic dissections. IAAAD patients treated with surgical or endovascular procedures had a lower unadjusted in-hospital and long-term mortality rate compared with medically managed patients. On the basis of the present natural history report, continued surveillance appears mandatory. To improve the life expectancy of patients with IAAAD, aggressive surgical or endovascular management seems justified.

Entities:  

Mesh:

Year:  2007        PMID: 17980278     DOI: 10.1016/j.jvs.2007.07.030

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  11 in total

Review 1.  Spontaneous arterial dissection: phenotype and molecular pathogenesis.

Authors:  Caspar Grond-Ginsbach; Rastislav Pjontek; Suna Su Aksay; Alexander Hyhlik-Dürr; Dittmar Böckler; Marie-Luise Gross-Weissmann
Journal:  Cell Mol Life Sci       Date:  2010-02-14       Impact factor: 9.261

2.  Dysregulated miR1254 and miR579 for cardiotoxicity in patients treated with bevacizumab in colorectal cancer.

Authors:  Ziyuan Zhao; Ju He; Jing Zhang; Meng Liu; Sin Yang; Nan Li; Xiaofeng Li
Journal:  Tumour Biol       Date:  2014-02-11

3.  Single-center experience in the management of spontaneous isolated abdominal aortic dissection.

Authors:  Dittmar Böckler; Claudio Bianchini Massoni; Philipp Geisbüsch; Maani Hakimi; Hendrik von Tengg-Kobligk; Alexander Hyhlik-Dürr
Journal:  Langenbecks Arch Surg       Date:  2015-09-22       Impact factor: 3.445

4.  Painless Type B Aortic Dissection: Insights From the International Registry of Acute Aortic Dissection.

Authors:  Jip L Tolenaar; Stuart J Hutchison; Dan Montgomery; Patrick O'Gara; Rosella Fattori; Reed E Pyeritz; Linda Pape; Toru Suzuki; Arturo Evangelista; Frans L Moll; Vincenzo Rampoldi; Eric M Isselbacher; Cristoph A Nienaber; Kim A Eagle; Santi Trimarchi
Journal:  Aorta (Stamford)       Date:  2013-07-01

5.  Isolated abdominal aortic dissection.

Authors:  Ee Ling Serene Tang; Choon Seng Chong; Sriram Narayanan
Journal:  BMJ Case Rep       Date:  2014-02-14

6.  Endovascular treatment of spontaneous isolated abdominal aortic dissection.

Authors:  Anna Maria Giribono; Doriana Ferrara; Flavia Spalla; Donatella Narese; Umberto Bracale; Felice Pecoraro; Renata Bracale; Luca Del Guercio; Umberto Marcello Bracale
Journal:  Acta Radiol Open       Date:  2016-12-05

7.  Endovascular Treatment of Infrarenal Isolated Abdominal Aortic Dissection with Application of the Kissing Stents Technique: A Case Report and Review of the Literature.

Authors:  Georgios Sahsamanis; Georgios Vourliotakis; Konstantinos Maltezos; Georgios Plakas; Vasileios Tzilalis
Journal:  Ann Vasc Dis       Date:  2017-09-25

Review 8.  Insights from the International Registry of Acute Aortic Dissection.

Authors:  Arturo Evangelista; Giuliana Maldonado; Doménico Gruosso; Gisela Teixido; Jose Rodríguez-Palomares; Kim Eagle
Journal:  Glob Cardiol Sci Pract       Date:  2016-03-31

9.  Endovascular Treatment of Spontaneous and Isolated Infrarenal Acute Aortic Syndrome with Unibody Aortic Stent-Grafts.

Authors:  Felice Pecoraro; Ettore Dinoto; Domenico Mirabella; Francesca Ferlito; Arduino Farina; David Pakeliani; Mario Lachat; Francesca Urso; Guido Bajardi
Journal:  World J Surg       Date:  2020-09-03       Impact factor: 3.352

10.  Incidence and natural history of isolated abdominal aortic dissection: A population-based assessment from 1995 to 2015.

Authors:  Indrani Sen; Mario D'Oria; Salome Weiss; Thomas C Bower; Gustavo S Oderich; Manju Kalra; Jill Colglazier; Randall R DeMartino
Journal:  J Vasc Surg       Date:  2020-08-27       Impact factor: 4.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.